Johnson & Johnson vs Teleflex Incorporated
JNJ vs TFX — side-by-side comparison from reported financials. JNJ leads 8, TFX leads 3 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
| Metric | JNJ | TFX |
|---|---|---|
| Price | $261.79 | $125.12 |
| Market cap | $631B | $5.30B |
| Revenue (TTM) | $97.9B | $6.05B |
| Revenue growth | +5.6% | -10.6% |
| Net margin | 21.5% | -16.7% |
| Free cash flow | $22.2B | $229M |
| Net cash (debt) | ($27.8B) | ($2.61B) |
| 1-year price return | +37.0% | +0.3% |
| P/E | 29.9 | 28.7 |
| P/E vs own history (cheap-side %) | 16% | 64% |
| Dividend yield | 2.00% | 1.13% |
| Return on equity | 26% | -32% |
| Altman Z-score | — | 1.93 |
| CV checks passed | 10 of 11 | 8 of 11 |
| Employees | 140,800 | 15,500 |
Full résumé-style profiles: JNJ CV · TFX CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.